Related Experiment Video
Updated: May 24, 2026

High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease
Published on: October 31, 2012
Expression of soluble HLA-G in multiple myeloma patients and patients with renal failure
Paulina Wlasiuk1, Anna Stec, Agnieszka Piechnik
1Department of Experimental Hematooncology, Medical University of Lublin, Lublin, Poland.
Abstract:
Human lymphocyte antigen-G (HLA-G) is an immunosuppressive molecule that induces functional silencing of immune component cells and can be responsible for immunosuppression in patients with multiple myeloma (MM). Immune dysfunction is an important feature of MM and leads to infections as well as may promote disease progression. Ninety-five patients were included in this study. In MM, the sHLA-G levels were increased when compared to healthy volunteers and the levels of sHLA-G correlated with concentration of creatinine. Interestingly, we detected high levels of sHLA-G in patients with renal insufficiency without any malignant disease but levels were lower than in MM.
